Rymo Technologies raises seed funding from IAN Group
20 Mar 2026, 11:55 AMThe robotic rehabilitation systems maker will use the fresh capital for product innovation, expansion of manufacturing capabilities, and to grow its presence within India and internationally.
Team Head&Tale
Share the story on
Block
Rymo Technologies has secured Rs 10 crore in a seed funding round led by IAN Group through its IAN Angel Fund, with participation from other angel investors.
The robotic rehabilitation systems maker will use the fresh capital for product innovation, expansion of manufacturing capabilities, to grow its presence within India, and scale internationally, including the Association of Southeast Asian Nations (ASEAN) countries and the Middle East, a statement said.
Rymo Technologies is a neuro-rehabilitation startup solving for the lack of advanced rehabilitation for patients in Tier 1 and 2 cities, and smaller hospitals, due to shortage in trained therapists and the high cost of robotic rehabilitation systems.
It provides physical rehabilitation equipment that uses advanced robotics, virtual reality and artificial intelligence (AI) technologies to help individuals regain mobility, and recover from strokes, injuries, and other neurological conditions.
The company has supported over 7,500 patients and provided more than 15,000 therapy hours, with 452 device installations across 354 healthcare clients, including AIIMS, Apollo Hospitals, and Manipal Hospitals.
The Navi Mumbai-based startup was founded in 2020 by Chirag Shah and Abhishek Rai to advance rehabilitation technology accessible to mid-sized hospitals and physiotherapy clinics, and enable them to provide the same quality of physical rehabilitation services available at large hospitals in metropolitan cities.
"Our goal is to democratise world-class rehabilitation so that no patient is left behind due to cost or infrastructure barriers. With this financing, we aim to expand internationally, advance our technology, and provide more patients and healthcare professionals access to superior robotic rehabilitation," said Chirag Shah, cofounder and CEO, Rymo Technologies.
The company has received the United States Food and Drug Administration (FDA) classification as a Class II medical device. It has also partnered with Fourier Rehab to expand into ASEAN markets.
It had previously raised $343,000 in seed capital across three rounds from investors such as IKP Knowledge Park, Keva and Social Alpha, as per market intelligence website Tracxn.
Who Reads Us
“I enjoy reading The Head and Tale for their coverage on the Fintech landscape. The reporting is incisive and honest, and it demonstrates a sharp understanding of the industry and the issues that concern it. I'd like to extend my best wishes to Arti for her continued success.”
“Well-researched, informative and analysis based reporting makes an interesting read. 'The Head and Tale' news portal has been demonstrating this quite well covering fintech and emerging tech sectors. Their timely updates, exclusive stories and different perspectives on these sectors help me stay informed. Kudos to Arti Singh for pursuing her passion and best wishes to the team.”
“The Head and Tale stands out for its deep industry knowledge and impressive network of sources. I especially appreciate that the reporting remains independent, rarely resorting to paid puff pieces, making it a publication I can genuinely trust. Having followed Arti’s work for years, I’ve come to rely on The Head and Tale for its unparalleled insight and truly independent coverage. Arti’s long-standing presence in the sector means her reporting is always informed, with access few can match.”
“What I really appreciate about The Head and Tale is that it doesn’t just report the news, it interprets it. The stories are well-researched, comprehensive, and bold. Arti brings a fearless lens to reporting, often asking the uncomfortable but necessary questions. She makes you pause, reflect, and rethink what it all means for the payments and fintech ecosystem. It’s rare to find journalism that’s this sharp, timely, and relevant to the work we do every day.”
“I’ve always valued journalism that goes beyond surface-level headlines. The Head and Tale does exactly that - it connects the dots, asks the tough questions, and brings clarity to the shifts shaping our evolving industry. I’ve even encouraged my team members to subscribe, because staying informed through credible, deeply reported stories is as important as building products. For me, The Head and Tale has become part of essential reading.”
Related News